Pharmaceutical stocks underperform S&P 500 by 10% over 6 months post-…

Market overview

If drug pricing reform passes, major pharmaceutical companies like Pfizer and Merck will face margin pressure. Investors are likely to price in regulatory risks, leading to relative underperformance compared to the broader market.

price prediction market

Implied probability (Yes)

65%

Source: user-generated

More price markets

• Bitcoin price exceeds $150,000 by end of 2026 — 68% Yes
• Bitcoin price recovers to $50,000 by December 2026 — 62% Yes
• Bitcoin price exceeds $100,000 within 6 months of Clarity Act passage — 70% Yes
• Coinbase stock to rise 15% by June 2026 amid crypto regulation clarity — 72% Yes
• NY crypto tax revenue will exceed $200M in 2027 — 65% Yes
• Will stock drop >15% on next financing terms? — 45% Yes
• Will enGene raise additional equity financing before Q1 2027? — 80% Yes
• Trading volume on Kalshi’s crypto futures exceeds $500M in first month — 60% Yes

Browse all price markets →